SENNOSIDE 8.6MG- sennoside 8.6mg tablet, film coated 
Strive Pharmaceuticals Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Laxative - Laxante (Sennoside 8.6mg)

Sennoside 8.6mg

croscarmellose sodium, dibasic calcium phosphate, hydroxypropyl methyl cellulose, magnesium stearate, polyethylene glycol

AgeStarting dosageMaximum dosage
adults and children 12 years of age and over2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Do not use

laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding

ask a health professional before use

Keep out of reach of children

Overdose Warning: In case of accidental overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms

Keep out of reach of children

Incase of accidental overdose, get medical help or contact a Poison Contril Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Laxative

CT11241

SENNOSIDE 8.6MG 
sennoside 8.6mg tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70692-112
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
Product Characteristics
ColorgrayScoreno score
ShapeROUND (BICONVEX) Size5mm
FlavorImprint Code S3
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70692-112-414 in 1 PACKAGE; Type 0: Not a Combination Product12/20/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33412/20/2018
Labeler - Strive Pharmaceuticals Inc. (080028013)

Revised: 11/2020
Document Id: 91d05a3f-15e4-f161-e053-2995a90a997c
Set id: 91d0c4ad-7329-6d49-e053-2a95a90a4091
Version: 1
Effective Time: 20201116
 
Strive Pharmaceuticals Inc.